|Articles|November 4, 2022
Supplements and Featured Publications
- Microinjection via the Suprachoroidal Space: A Review of a Novel Mode of Administration
- Volume 28
- Issue 13
Participating Faculty: Microinjection via the Suprachoroidal Space: A Review of a Novel Mode of Administration
Author(s)Thomas Ciulla, MD, MBA, Steven Yeh, MD
Advertisement
FACULTY
Thomas Ciulla, MD, MBA
Chief Medical Officer & Chief Development Officer Clearside Biomedical
Alpharetta, GA
Volunteer Clinical Professor
Indiana University School of Medicine Indianapolis, Indiana
Steven Yeh, MD
Professor of Ophthalmology Truhlsen Eye Institute
University of Nebraska Medical Center Omaha, NE
FACULTY DISCLOSURES
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Thomas Ciulla, MD, MBA
STOCK OWNERSHIP
Clearside Biomedical
EMPLOYMENT
Clearside Biomedical
Steven Yeh, MD
CONSULTANCIES OR PAID ADVISORY BOARDS
Bausch + Lomb, Adverum Biotechnologies, REGENXBIO
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
AI Chatbots Score Below 28% on Colorectal Cancer Questions
2
5 Notable FDA Approvals From the First Half of 2026
3
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
4
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
5
